In vitro diagnostics market will witness additional growth of $33.16 billion; 35% growth in North America – Technavio

New YorkAnd the October 13, 2022 /PRNewswire/ – file Global In Vitro Diagnostics Market The volume is expected to increase by 33.16 billion US dollars, accelerating at a compound annual growth rate of 6.89% during the forecast period. According to Technavio’s report, the market will witness the highest incremental growth in North Amarica. The region will account for 35% of the global market share during the forecast period. Factors such as increased insurance coverage, increased spending on research and development, and the growth of the elderly population with chronic diseases contribute significantly to the growth of the regional market. Explore future growth opportunities in various regions in detail. Buy a report now

Technavio announced its latest market research report, Global In-vitro Diagnostics Market 2022-2026

Technavio announced its latest market research report, Global In-vitro Diagnostics Market 2022-2026

The market is driven by factors such as the aging population, chronic and infectious diseases, rising demand for personalized medicine, and increasing investments in drug discovery. To take advantage of the current opportunities, market vendors must consolidate their foothold in the fast-growing sectors while maintaining their positions in the slow-growing sectors.

The report covers the following areas:

In Vitro Diagnostics Market 2022-2026: Segmentation

The market growth in the immunoassay segment will be significant during the forecast period. Immunoassay is a technique primarily focused on identifying and documenting high-resolution intracellular and tissue components such as proteins and lipopolysaccharides in clinical diagnosis and medical research laboratories. It is used for disease diagnosis, biological research, and drug development applications, driving sector growth.

About 35% of the overall market growth is expected to come from North Amarica during the forecast period. The growth of the regional market can be attributed to higher spending on healthcare and increased promotions around the use of POC tests for early detection of diseases.

Get deeper insights into the contribution of each business sector and region to the growth of the global market by purchasing our complete report. Get started by downloading a free sample

In Vitro Diagnostics Market 2022-2026: Vendor Analysis & Scope

To help companies improve their market position, Laboratory Diagnostics Market provides detailed analysis of around 25 vendors operating in the market. Some of these sellers are:

  • Abbott Laboratories: The company offers in vitro diagnostics such as the Alinity H-Series and CELL DYN Ruby.

  • Danaher Company: The company offers laboratory diagnostics such as the HemoCue Hb 801 system.

  • Diasurin Spa: The company offers in vitro diagnostics such as DiaSorin LIAISON Calprotectin Assay.

  • Hoffmann Laroche Ltd: The company offers in vitro diagnostics such as Elecsys Anti SARS CoV 2.

  • Illumina Corporation: The company offers in vitro diagnostics such as the Illumina COVIDSeq test.

  • Agilent Technologies Inc.

  • arkray company

  • Becton Dickinson Share.

  • BGI . group

  • Bio-Rad Laboratories Company

  • bioMerieux SA

  • Grivols SA

  • Ortho Clinical Diagnostics plc. Ortho Clinical Diagnostics


  • Quest Diagnostics Inc.

  • Siemens AG

  • Sysmex Corporation

  • Thermo Fisher Scientific Inc.

In Vitro Diagnostics Market 2022-2026: Key Points

  • The compound annual growth rate of the market during the forecast period 2022-2026

  • Detailed information on the factors that will help the growth of the in vitro diagnostics market over the next five years

  • Estimation of the In Vitro Diagnostics market size and its contribution to the parent market

  • Forecasting upcoming trends and changes in consumer behavior

  • In vitro diagnostics market growth

  • Analysis of the competitive landscape of the market and detailed information of the vendors

  • Comprehensive details of factors that will challenge the growth of in vitro diagnostic market vendors

Related reports:

In vitro diagnostics market scope

Report coverage


page number


base year


prediction period


Growth Momentum and CAGR

Acceleration at a compound annual growth rate of 6.89%

Market growth 2022-2026

33.16 billion US dollars

Market Structure, Market Structure


Annual Growth (%)


Regional Analysis

North America, Europe, Asia and the rest of the world (ROW)

Market share performance

North America 35%

Main consuming countries

The United States, Canada, Germany, China and Japan

Competitive scene

Leading companies, competitive strategies and scope of consumer engagement

Company Profile

Abbott Laboratories, Agilent Technologies Inc. ARKRAY Inc. , Becton Dickinson and Co. , BGI Group, Bio Rad Laboratories Inc. , bioMerieux SA, Danaher Corp. , DiaSorin SpA, F. Hoffmann La Roche Ltd. , Grifols S.A., Illumina Inc. and Ortho Clinical Diagnostics plc, QIAGEN NV, and Quest Diagnostics Inc. and Siemens AG, Sysmex Corp, and Thermo Fisher Scientific Inc.

market dynamics

Key market analysis, market growth triggers and obstacles, analysis of fast-growing and slow-growing segments, impact of COVID-19 and future consumer dynamics, market status analysis for the forecast period.

field of customization

If our report doesn’t include the data you’re looking for, you can access our analysts and customize the segments.

table of contents:

1. Executive Summary

2 market view

3 market sizing

4 Five forces analysis

5 Market segmentation through technology

6 customer perspective

7 Geographical scene

8 Drivers, Challenges and Trends

9 landscape seller

10 Vendor Analysis

Appendix 11

information about us

Technavio is a global leader in technology research and consulting. Their research and analysis focus on emerging market trends and provide actionable insights to help companies identify market opportunities and develop effective strategies to improve their market positions. With over 500 dedicated analysts, Technavio’s reporting library consists of more than 17,000 reports and statistics, covering 800 technologies, spanning across 50 countries. Their client base consists of organizations of all sizes, including more than 100 Fortune 500 companies. This growing client base relies on Technavio’s comprehensive coverage, extensive research, and actionable market insights to identify opportunities in current and potential markets and to assess their competitive positions in changing market scenarios. .


Technavio Research
Jesse Maeda
Marketing and Media Executive
United States: +1844364 1100
United Kingdom: +44 203893 3200

Global In Vitro Diagnostics Market 2022-2026

Global In Vitro Diagnostics Market 2022-2026



View original content for multimedia download: America – technavio-301648825.html

The source is Technavio

Leave a Comment